Laverdia-CA1 provides an additional treatment option for dogs suffering from this devastating illness.
A renowned veterinary oncologist outlines the current knowledge about this cancer of the blood vessel walls, from presentation to prognosis.
Cancer diagnostics and therapeutics continue to evolve, potentially lessening the associated invasiveness, duration, and cost.
These 1-hour events will address a wide array of veterinary topics including owner compliance, pet insurance, oncology, and telemedicine.
The simple blood test employs technology that looks for very early nucleosomic markers of cancer in dogs.